ClinicalTrials.Veeva

Menu

Porcine Acellular Dermal Matrix for the Treatment of Localized Gingival Recessions

U

University of Campinas, Brazil

Status

Completed

Conditions

Gingival Recession

Treatments

Device: Porcine acellular dermal matrix
Other: Coronally advanced flap (CAF)

Study type

Interventional

Funder types

Other

Identifiers

NCT06006780
59036822.4.1001.5418

Details and patient eligibility

About

Aim: The aim of this randomized clinical trial is to evaluate the use of the porcine acellular dermal matrix (PADM) for the treatment of RT1 localized gingival recessions.

Material and methods: Forthy patients (n=20) with RT1 localized gingival recessions with height ranging from 3 to 5 mm with and at least, 2mm of keratinized tissue width will be selected to participate in the study. Patients will be allocated randomly in two treatment groups: Coronally advanced flap (CAF) or coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM). The clinical parameters evaluated at the baseline, 6 and 12 months will be: Plaque index (IPL); gingival index (GI); relative gingival recession height (RGRH); gingival recession width (GRW); probing depth (PD); relative clinical attachment level (RCAL); keratinized tissue height (KTH); keratinized tissue thickness (KTT); papilla height (PH). Evaluations will be made by the professional and the patient regarding dentin hypersensitivity (HD) (Schiff and VAS scales respectively), aesthetics (RES and VAS scales, respectively) and patient's centered outcomes, through the questionnaire referring to the OHIP-14.

Descriptive statistical analysis will be expressed as mean ± standard deviation (SD), median, quartiles, percentages and confidence intervals (95% CI). To analyze the normality of the residue, the Shapiro-Wilk test will be performed. Then, the Wilcoxon test will be applied to compare the periodontal parameters and a quality of life, before and post-treatment. Correlations between parameters and dental hypersensitivity will be analyzed through Spearman's test. Key words: Gingival recession, Root coverage, Biomaterial, Acellular dermal matrix.

Enrollment

40 patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • RT1 localized gingival recessions with height ranging from 3 to 5 mm;
  • 2mm or more of keratinized tissue width ;
  • Probing depth less than 3mm;
  • Plaque and gingival index less or equal to 20%.

Exclusion criteria

  • Smokers;
  • Pregnants;
  • Nursing;
  • Patients with diabetes mellitus or another condition that interfere in the tissue repair
  • Patients who use drugs or medications that interfere in the tissue repair;
  • Allergies to any composition of the devices of the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

40 participants in 2 patient groups

Coronally advanced flap (CAF)
Active Comparator group
Treatment:
Other: Coronally advanced flap (CAF)
Coronally advanced flap associated with the porcine acellular dermal matrix (CAF+ PADM)
Experimental group
Treatment:
Device: Porcine acellular dermal matrix

Trial contacts and locations

1

Loading...

Central trial contact

Enilson A. Sallum, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems